FDA Approved: MESALAMINE — Supplemental Application (Actavis Pharma, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Mesalamine from Actavis Pharma, Inc. under ANDA203817, indicating an update for the generic product (such as labelin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Mesalamine (Mesalamine)

Snippet

SUPPL AP for MESALAMINE (MESALAMINE)